COVID-19 cases in India cross 32 lakh mark, recovery rate rises to 75.92%

• The country breached the 30-lakh mark on August 23 and added more than two lakh fresh Covid cases in just three days.
• Recoveries have crossed the 24-lakh mark and surged to 24,67,758 with 63,173 more people recuperating in the past 24 hours, taking the recovery rate to 75.92 per cent.

With 67,151 fresh coronavirus infections in 24 hours, India's tally mounted to 32,34,474 on Wednesday, while the death toll climbed to 59,449 with 1,059 more fatalities, said the Health Ministry.

The actual caseload is the active cases, which currently stands at 7,07,267. The silver lining is that the recoveries are over three times more than the active cases.

The country breached the 30-lakh mark on August 23 and added more than two lakh fresh Covid cases in just three days.

Recoveries have crossed the 24-lakh mark and surged to 24,67,758 with 63,173 more people recuperating in the past 24 hours, taking the recovery rate to 75.92 per cent.

Out of the total active cases, 2.7 per cent patients are on oxygen support, 1.92 per cent patients in intensive care units (ICU) and 0.29 per cent are on ventilator support.

In India the fatality rate, which is the proportion of people who die from the disease among individuals diagnosed, has dropped to 1.84 per cent, the Health Ministry said.

As per Ministry's data, 87 per cent of deaths due to coronavirus were recorded among people aged 45 and above, while people in the 60-years and above category were among the 51 per cent of total deaths. Meanwhile, the mortality rate among people under 26 years of age was 2 per cent.

According to the Indian Council of Medical Research, a cumulative of 3,76,51,512 samples have been tested till August 25 with 8,23,992 samples being tested on Tuesday.

Maharashtra continues to be the worst-hit with a total of 6,93,398 cases and 22,465 deaths; followed by Tamil Nadu with 3,85,352 cases and 6,614 deaths. Andhra Pradesh, Karnataka, Uttar Pradesh, Delhi, West Bengal, and Bihar come next.

SEE ALSO:
Oxford-Astrazeneca COVID-19 Vaccine: Phase II trials will begin in India today